Search

Author/Creator Sullivan, Daniel M.

2. Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies. (29th December 2015)

Authors:
Reed, Damon R.; Mascarenhas, Leo; Manning, Kathleen; Hale, Gregory A.; Goldberg, John; Gill, Jonathan; Sandler, Eric; Isakoff, Michael S.; Smith, Tiffany; Caracciolo, Jamie; Lush, Richard M.; Juan, Tzu‐Hua; Lee, Jae K.; Neuger, Anthony M.; Sullivan, Daniel M.
Journal:
Cancer medicine
Issue:
Volume 5:Number 2(2016:Feb.)
Page Start:
294
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer. (30th September 2016)

Authors:
Chiappori, Alberto A.; Otterson, Gregory A.; Dowlati, Afshin; Traynor, Anne M.; Horn, Leora; Owonikoko, Taofeek K.; Ross, Helen J.; Hann, Christine L.; Abu Hejleh, Taher; Nieva, Jorge; Zhao, Xiuhua; Schell, Michael; Sullivan, Daniel M.
Journal:
Oncologist
Issue:
Volume 21:Number 10(2016)
Page Start:
1163
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Lenalidomide‐based response‐adapted therapy for older adults without high risk myeloma. (12th December 2018)

Authors:
Baz, Rachid; Naqvi, Syeda Mahrukh Hussnain; Lee, Jae‐Hoon; Brayer, Jason; Hillgruber, Nancy; Fridley, Brooke L.; Shain, Kenneth H.; Sullivan, Daniel M.; Alsina, Melissa
Journal:
British journal of haematology
Issue:
Volume 184:Number 5(2019)
Page Start:
735
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Rapid Screening of Novel Agents for Combination Therapy in Sarcomas. (24th October 2013)

Authors:
Cubitt, Christopher L.; Menth, Jiliana; Dawson, Jana; Martinez, Gary V.; Foroutan, Parastou; Morse, David L.; Bui, Marilyn M.; Letson, G. Douglas; Sullivan, Daniel M.; Reed, Damon R.
Other Names:
Raut Chandrajit Premanand Academic Editor.
Journal:
Sarcoma
Issue:
Volume 2013(2013)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. A Randomized Phase II Study of Linsitinib (OSI‐906) Versus Topotecan in Patients With Relapsed Small‐Cell Lung Cancer. (30th September 2016)

Authors:
Chiappori, Alberto A.; Otterson, Gregory A.; Dowlati, Afshin; Traynor, Anne M.; Horn, Leora; Owonikoko, Taofeek K.; Ross, Helen J.; Hann, Christine L.; Abu Hejleh, Taher; Nieva, Jorge; Zhao, Xiuhua; Schell, Michael; Sullivan, Daniel M.
Journal:
Oncologist
Issue:
Volume 21:Number 10(2016)
Page Start:
1163
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Phase II study of pegylated liposomal doxorubicin, low‐dose dexamethasone, and lenalidomide in patients with newly diagnosed multiple myeloma. Issue 1 (January 2014)

Authors:
Baz, Rachid C.; Shain, Kenneth H.; Hussein, Mohamad A.; Lee, Ji‐Hyun; Sullivan, Daniel M.; Oliver, Elizabeth Finley; Nardelli, Lisa A.; Nodzon, Lisa A.; Zhao, Xiuhua; Ochoa‐Bayona, Jose Leonel; Nishihori, Taiga; Dalton, William S.; Alsina, Melissa
Journal:
American journal of hematology
Issue:
Volume 89:Issue 1(2014:Jan.)
Page Start:
62
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗